Repeated arsenic trioxide intravenous infusion causes focal bone marrow necrosis in two acute promyelocytic leukemia patients.
Zhou
Jin
J
Department of Internal Medicine, the First Hospital of Harbin Medical University, Harbin 150001. Jinzhou@lycos.com
Meng
Ran
R
Sui
Xin-hua
XH
Yang
Bao-feng
BF
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects*; D001853:Bone Marrow / Q000473:pathology*; D001855:Bone Marrow Diseases / Q000139:chemically induced*; D002648:Child; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008297:Male; D009336:Necrosis; D010087:Oxides / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide